Evaluation of Hepatitis B, Hepatitis A, Measles, Rubella, Mumps and Varicella Antibody Seroprevalences in Vocational School of Health Students

Evaluation of Hepatitis B, Hepatitis A, Measles, Rubella, Mumps and Varicella Antibody Seroprevalences in Vocational School of Health Students

Objective: In the present study, we investigated the seroprevalence of antibodies against hepatitis B, hepatitis A, measles, mumps, rubella and varicella viruses in adolescent students of a Vocational School of Health and aimed to contribute to the future studies intended to increase the vaccination...

Full description

Bibliographic Details
Main Author:	Aysun Kara Uzun
Format:	Article
Language:	English
Published:	Rabia Yılmaz 2020-06-01
Series:	Journal of Contemporary Medicine
Subjects:	adolescent health care workers seroprevalence vaccination
Online Access:	https://dergipark.org.tr/tr/download/article-file/1113548

Similar Items

Evaluation of Hepatitis A, Hepatitis B, Hepatitis C, HIV, Mumps, Measles and Chickenpox Seroprevalence in Healthcare Workers
by: Serkan Elarslan, et al.
Published: (2020-10-01)

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy
by: Brunella Perfetto, et al.
Published: (2024-03-01)

Seroepidemiology of Measles, Mumps, Rubella and Varicella in Italian Female School Workers: A Cross-Sectional Study
by: Nicola Frau, et al.
Published: (2021-10-01)

Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students
by: Sheek-Hussein Mohamud, et al.
Published: (2012-12-01)

Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review
by: Ryota Hase, et al.
Published: (2022-01-01)

Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations
by: Marco Fonzo, et al.
Published: (2022-07-01)

Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran
by: Shahrokh Izadi, et al.
Published: (2018-06-01)

Seroprevalence of varicella antibodies in adults without clinical history of disease
by: Konrad Silva Büchele, et al.
Published: (2020-01-01)

Dynamics of maternally transferred antibodies against measles, mumps, and rubella in infants in Sri Lanka
by: Nadhikala Muthiah, et al.
Published: (2021-06-01)

Evaluation of Measles, Rubella, Mumps, Hepatitis B and Varicella Zoster Antibodies in Medical and Dental Students in Shiraz, Iran
by: Afagh Moattari, et al.
Published: (2014-04-01)

Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany — A nationwide multi-center cross-sectional study
by: Wiebke Graf, et al.
Published: (2024-05-01)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
by: Zary Nokhodian, et al.
Published: (2022-02-01)

Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
by: Beatrice Zanella, et al.
Published: (2020-10-01)

Immunization Status against Measles, Mumps, Rubella and Varicella in a Large Population of Internationally Adopted Children Referred to Meyer Children’s University Hospital from 2009 to 2018
by: Angela Bechini, et al.
Published: (2020-01-01)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
by: Kayla E. Hanson, et al.
Published: (2023-04-01)

Vacinas contra varicela e vacina quádrupla viral Varicella vaccines and measles, mumps, rubella, and varicella vaccine
by: Lucia Ferro Bricks, et al.
Published: (2006-07-01)

Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea
by: Ji Hyun Yun, et al.
Published: (2022-11-01)

Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context
by: Giacomo Casabona, et al.
Published: (2023-12-01)

Measles seroprevalence among healthcare workers in South Korea during the post-elimination period
by: Seung Beom Han, et al.
Published: (2021-08-01)

Seroprevalence of Measles, Rubella and Mumps Antibodies in Foreign Citizens Registered in Moscow Region (Labour Migrants)
by: T. A. Semenenko, et al.
Published: (2017-06-01)

Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
by: Stephen Ezeji-Okoye, et al.
Published: (2021-04-01)

Measles seroprevalence in Thailand: are adolescents and young adults at risk of measles?
by: Panit Takkinsatian, et al.
Published: (2024-06-01)

Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000-01-01)

Seroprevalence of measles, mumps, and rubella and genetic characterization of mumps virus in Khartoum, Sudan
by: Omer Adam, et al.
Published: (2020-02-01)

Will We Have a Cohort of Healthcare Workers Full Vaccinated against Measles, Mumps, and Rubella?
by: Andrea Trevisan, et al.
Published: (2020-02-01)

Seroprevalence of rubella in infertile women and the need for preconceptional vaccination
by: Shakeela Ishrat, et al.
Published: (2016-07-01)

Increasing Measles Seroprevalence in a Sample of Pediatric and Adolescent Population of Tuscany (Italy): A Vaccination Campaign Success
by: Beatrice Zanella, et al.
Published: (2020-09-01)

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia
by: Simone Santana Viana, et al.
Published: (2012-01-01)

Assessment of the Clinical and Economic Impact of Different Immunization Protocols of Measles, Mumps, Rubella and Varicella in Internationally Adopted Children
by: Sara Boccalini, et al.
Published: (2020-02-01)

Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.
by: Jolice P van den Berg, et al.
Published: (2014-01-01)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
by: Paolo Bonanni, et al.
Published: (2020-06-01)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
by: Huy Quang Quach, et al.
Published: (2022-11-01)

Application of a mixture model to assess the effect of measles-mumps-rubella vaccine on the mumps epidemic in children from kindergarten to early school age in Jiangsu Province, China
by: Lei Zhang, et al.
Published: (2018-11-01)

Measles-mumps-rubella vaccination experience in children with egg allergy
by: Öner Özdemir, et al.
Published: (2024-02-01)

Seroprevalence of diphtheria and measles antibodies and their association with demographics, self-reported immunity, and immunogenetic factors in healthcare workers in Latvia
by: Aija Leidere-Reine, et al.
Published: (2022-04-01)

Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey
by: Metin Kaya Gürgöze, et al.
Published: (2006-07-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

Seroprevalence of tetanus and pertussis antibodies among health care workers in Wuhu, China
by: Wei Shi, et al.
Published: (2024-12-01)

Herd immunity to vaccine preventable infections in Saint Petersburg and the Leningrad region: serological status of measles, mumps, and rubella
by: A. Yu. Popova, et al.
Published: (2024-12-01)

Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
by: Aslı Karadeniz, et al.
Published: (2020-04-01)